The visceral leishmaniasis treatment market is growing as global health efforts increase access to therapies like amphotericin B, miltefosine, and novel oral agents, especially in endemic regions facing high disease burden. https://www.datamintelligence.com/research-report/visceral-leishmaniasis-treatment-market